tiprankstipranks
Medicskin Holdings Ltd. (HK:8307)
:8307
Hong Kong Market
Want to see HK:8307 full AI Analyst Report?

Medicskin Holdings Ltd. (8307) AI Stock Analysis

1 Followers

Top Page

HK:8307

Medicskin Holdings Ltd.

(8307)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - 5.2)
Rating:47Neutral
Price Target:
HK$0.17
▼(-2.94% Downside)
Action:Reiterated
Date:06/24/26
The score is held down primarily by elevated balance-sheet leverage, weak/volatile recent revenue trends, and a sharp gross margin decline, which together increase financial risk and reduce earnings visibility. Technicals provide partial support with price above major moving averages, but overbought RSI and a slightly negative MACD temper that strength. Valuation is also a headwind because a negative P/E reflects unstable profitability and limits comparability.
Positive Factors
Consistent cash generation
Sustained positive operating and free cash flow provides a durable liquidity buffer that funds operations, modest capex and working capital without immediate reliance on equity markets. This supports survival through cyclical dips and enables incremental deleveraging or targeted reinvestment over months.
Negative Factors
Elevated leverage
Very high debt-to-equity materially reduces financial flexibility and raises refinancing and covenant risk. With limited equity relative to assets, any further earnings weakness or cash flow volatility could force painful deleveraging or asset sales, constraining strategic choices over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent cash generation
Sustained positive operating and free cash flow provides a durable liquidity buffer that funds operations, modest capex and working capital without immediate reliance on equity markets. This supports survival through cyclical dips and enables incremental deleveraging or targeted reinvestment over months.
Read all positive factors

Medicskin Holdings Ltd. (8307) vs. iShares MSCI Hong Kong ETF (EWH)

Medicskin Holdings Ltd. Business Overview & Revenue Model

Company Description
Medicskin Holdings Limited, an investment holding company, provides medical skin care services in Hong Kong. The company operates Medicskin centers, which provides various medical skin care services for the treatment of skin diseases and problems,...

Medicskin Holdings Ltd. Financial Statement Overview

Summary
Financials are mixed and risk-tilted: revenue has been volatile and recently weak (FY2026 down ~16%), profitability was negative for FY2023–FY2025 with only a small return to profit in FY2026 (~2% net margin), and gross margin fell sharply to ~37% (cost/mix pressure). A key support is consistently positive operating and free cash flow, but leverage is elevated (debt-to-equity ~3.4x in FY2026) with relatively small equity, limiting flexibility.
Income Statement
46
Neutral
Balance Sheet
32
Negative
Cash Flow
55
Neutral
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue47.87M45.11M49.88M45.54M49.15M
Gross Profit17.53M22.87M39.39M36.68M42.14M
EBITDA7.48M6.29M6.78M6.40M14.55M
Net Income936.00K-3.38M-3.05M-3.54M3.92M
Balance Sheet
Total Assets51.07M57.44M40.06M46.37M56.67M
Cash, Cash Equivalents and Short-Term Investments29.46M17.34M6.93M6.37M15.47M
Total Debt17.57M22.79M5.76M11.93M18.67M
Total Liabilities45.84M53.25M32.48M35.21M42.49M
Stockholders Equity5.23M4.20M10.95M14.47M17.43M
Cash Flow
Free Cash Flow4.54M8.29M9.12M946.00K2.33M
Operating Cash Flow5.81M9.13M10.52M3.25M4.29M
Investing Cash Flow-7.63M-191.00K-1.40M-5.67M-1.82M
Financing Cash Flow-5.22M1.48M-7.21M-6.74M-17.94M

Medicskin Holdings Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.17
Price Trends
50DMA
0.13
Negative
100DMA
0.15
Negative
200DMA
0.16
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
47.42
Neutral
STOCH
64.21
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8307, the sentiment is Negative. The current price of 0.17 is above the 20-day moving average (MA) of 0.12, above the 50-day MA of 0.13, and above the 200-day MA of 0.16, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 47.42 is Neutral, neither overbought nor oversold. The STOCH value of 64.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8307.

Medicskin Holdings Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
HK$805.83M14.104.33%1.99%11.23%-31.73%
62
Neutral
HK$4.23B10.6833.37%1.97%16.70%38.98%
60
Neutral
HK$1.03B31.731.27%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
49
Neutral
HK$61.28M31.321.67%-4.86%
47
Neutral
HK$66.65M-45.19-19.93%6.13%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8307
Medicskin Holdings Ltd.
0.12
>-0.01
-3.17%
HK:1846
EuroEyes International Eye Clinic Limited
2.40
-0.47
-16.38%
HK:2135
Raily Aesthetic Medicine International Holdings Limited
0.11
-0.02
-11.81%
HK:2373
Beauty Farm Medical & Health Industry, Inc.
17.00
-11.48
-40.31%
HK:6639
Arrail Group Ltd.
1.83
-0.31
-14.53%
HK:2508
Saint Bella Inc.
3.68
-2.87
-43.82%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 24, 2026